Intracellular pool of vascular endothelial growth factor in human neutrophils

Blood

Volumn 90, Issue 10, 1997, Pages 4153-4161

  Gaudry, Murielle ^a   Brégerie, Olivier ^a   Andrieu, Valérie ^a   El Benna, Jamel ^a   Pocidalo, Marie Anne ^a   Hakim, Jacques ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; CYTOCHALASIN B; FORMYLMETHIONYLLEUCYLPHENYLALANINE; PENTOXIFYLLINE; PHORBOL 13 ACETATE 12 MYRISTATE; POLYCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL FRACTIONATION; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; MICROVASCULATURE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN CONTENT; T LYMPHOCYTE ACTIVATION; VASCULAR ENDOTHELIUM;

EID: 1842366022     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.10.4153     Document Type: Article

References (35)

1. Cassatella MA: The production of cytokines by polymorphonuclear neutrophils. Immunol Today 16:21, 1995
2. Dubravec DB, Spriggs DR, Mannick JA, Rodrick ML: Circulating human peripheral blood granulocytes synthetize and secrete tumor necrosis factor α. Proc Natl Acad Sci USA 87:6758, 1990
3. Kasam T, Streiter RM, Lukacs NW, Burdick MD, Kunkel SL: Regulation of neutrophil-derived chemokine expression by IL-10. J Immunol 152:3559, 1994
4. Gasperini S, Calzetti F, Russo MP, De Gironcoli M, Cassatella MA: Regulation of GRO α production in human granulocytes. J Inflamm 45:143, 1995
5. Grotendorst GR, Smale G, Pencev D: Production of transforming growth factor beta by human blood monocytes and neutrophils. J Cell Physiol 140:396, 1989
6. Kolch W, Martiny-Baron G, Kieser A, Marmé D: Regulation of the expression of the VEGF/VPS and its receptors: Role in tumor angiogenesis. Breast Cancer Res Treat 36:139, 1995
7. Thomas KA: Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 271:603, 1996
8. Paleolog EM: Angiogenesis: A critical process in the pathogenesis of RA - A role for VEGF? Br J Rheum 35:917, 1996
9. Colville-Nash PR, Scott DL: Angiogenesis and rheumatoid athritis: Pathogenic and therapeutic implications. Ann Rheum Dis 51:919, 1992
10. Oliver SJ, Cheng TP, Banquerigo ML, Brahn E: Suppression of collagen-induced arthritis by an angiogenesis inhibitor, AGM-1470, in combination with cyclosporin: Reduction of vascular endothelial growth factor (VEGF). Cell Immunol 166:196, 1995
11. Fava RA, Olsen NJ, Spencer-Green G, Yeo K, Berse B, Jackman RW, Senger DR, Dvorak HF, Brown LF: Vascular permeability factor/endotheliai growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 180:341, 1994
12. Freeman MR, Schneck FX, Gagnon ML, Corless C, Soker S, Niknejad K, Peoples GE, Klagsburn M: Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: A potential role for T cells in angiogenesis. Cancer Res 55:4140, 1995
13. Soker S, Fidder H, Neufeld G, Klagsbrun M: Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF(165) via its exon 7-encoded domain. J Biol Chem 271:5761, 1996
14. Namiki A, Brogi E, Kearney M, Kim EA, Wu TG, Couffinhal T, Varticovski L, Isner JM: Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem 270:31189, 1995
15. Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela O, Alitalo K: Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells. J Biol Chem 269:6271, 1994
16. Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C: Macrophages and angiogenesis. J Leukoc Biol 55:410, 1994
17. Kowanko IC, Ferrante A: Adhesion and TNF priming in neutrophil-mediated cartilage damage. Clin Immunol Immunopathol 79:36, 1996
18. Van Leeuwen MA, Westra J, Limburg PC, Van Riel PL, Van Rijswijk MH: Interleukin-6 in relation to other proinflammatory cytokines, chemotactic activity and neutrophil activation in rheumatoid synovial fluid. Ann Rheum Dis 54:33, 1995
19. Lefkowitz DL, Mills K, Lefkowitz SS, Bollen A, Moguilevsky N: Neutrophil-macrophage interaction: A paradigm for chronic inflammation. Med Hypotheses 44:58, 1995
20. Yamashita J, Ogawa M, Shirakusa T: Free-form neutrophil elastase is an independent marker prediciting recurrence in primary breast cancer. J Leukoc Biol 57:375, 1995
21. Mayer M: Biochemical and biological aspects of the plasminogen activation system. Clin Biochem 23:197, 1990
22. Kummer JA, Abbink JJ, de Boer JP, Roem D, Nieuwenhuys EJ, Kamp AM, Swaak TJ, Hack CE: Analysis of intraarticular fibrinolytic pathways in patients with inflammatory and noninflammatory joint diseases. Arthritis Rheum 35:884, 1992
23. Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, Nadaf S, Kavanaugh D, Carbone DP: Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of demritic cells. Nat Med 2:1096, 1997
24. Borregaard N, Heiple JM, Simons ER, Clark RA: Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: Translocation during activation. J Cell Biol 97:52, 1983
25. Gaudry M, Gilbert C, Barabe F, Poubelle PE, Naccache PH: Activation of lyn is a common element of the stimulation of human neutrophils by soluble and particulate agonists. Blood 86:3567, 1995
26. Richter J, Andersson T, Olsson I: Effect of tumor necrosis factor and granulocyte/macrophage colony-stimulating factor on neutrophil degranulation. J Immunol 142:3199, 1989
27. Currie MS, Murali K, Rao K, Padmanabhan J, Jones A, Crawford J, Cohen HJ: Stimulus-specific effects of pentoxifylline on neutrophil CR3 expression, degranulation, and Superoxide production. J Leukoc Biol 47:244, 1990
28. Kjeldsen L, Bainton DF, Sengelov H, Borregaard N: Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophilss. Blood 83:799, 1994
29. Detmar M, Brown LF, Claffey KP, Yeo K, Kocher O, Jackman RW, Berse B, Dvorak HF: Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptor in psoriasis. J Exp Med 180:1141, 1994
30. McLaren J, Prentice A, Charnock-Jones DS, Millican SA, Müller KH, Sharkey AM, Smith SK: Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J Clin Invest 98:482, 1996
31. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Einer VM, Einer SG, Stricter RM: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258:1798, 1992
32. Shen H, Clauss M, Ryan J, Schmidt A-M, Tijburg P, Borden L, Connolly D, Stern D, Kao J: Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood 81:2767, 1993
33. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, Pope RM, Ferrara N: Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 152:4149, 1994
34. Klagsbrun M, Soker S: VEGF/VPS: The angiogenesis factor bound? Curr Biol 3:699, 1993
35. Stricter RM, Poverini PJ, Arenberg DA, Walz A, Opdenakker G, Van Damme J, Kunkel SL: Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J Leukoc Biol 57:752, 1995